Literature DB >> 24371632

Metastatic adenocarcinoma found in inguinal, pelvic and para-aortic lymph nodes 14 years following hysterectomy for adenocarcinoma in situ of the cervix.

Anthony B Costales1, Patricia J Eifel2, Michael T Deavers3, Michael Frumovitz1, Kathleen M Schmeler1.   

Abstract

► Recurrent invasive adenocarcinoma after definitive therapy for AIS is a rare occurrence. ► Because of its unpredictable nature, AIS requires long-term and close surveillance.

Entities:  

Keywords:  Adenocarcinoma; Adenocarcinoma in situ; Cervix

Year:  2012        PMID： 24371632      PMCID： PMC3861022          DOI： 10.1016/j.gynor.2012.05.001

Source DB:  PubMed          Journal:  Gynecol Oncol Case Rep        ISSN： 2211-338X


  11 in total

1.  Recurrent invasive adenocarcinoma after hysterectomy for cervical adenocarcinoma in situ.

Authors:  T C Krivak; B Retherford; S Voskuil; G S Rose; T Alagoz
Journal:  Gynecol Oncol       Date:  2000-05       Impact factor: 5.482

2.  Conservative management of adenocarcinoma in situ of the cervix.

Authors:  C H Shin; J O Schorge; K R Lee; E E Sheets
Journal:  Gynecol Oncol       Date:  2000-10       Impact factor: 5.482

3.  Adenocarcinoma in situ of the uterine cervix: an experience with 100 cases.

Authors:  A G Ostör; A Duncan; M Quinn; R Rome
Journal:  Gynecol Oncol       Date:  2000-11       Impact factor: 5.482

4.  Fertility sparing treatment for in situ and early invasive adenocarcinoma of the cervix.

Authors:  M T McHale; T D Le; R A Burger; M Gu; J L Rutgers; B J Monk
Journal:  Obstet Gynecol       Date:  2001-11       Impact factor: 7.661

Review 5.  Adequacy of conization margins in adenocarcinoma in situ of the cervix as a predictor of residual disease.

Authors:  D D Im; L R Duska; N B Rosenshein
Journal:  Gynecol Oncol       Date:  1995-11       Impact factor: 5.482

Review 6.  Cervical adenocarcinoma in situ.

Authors:  M P Hopkins; J A Roberts; R W Schmidt
Journal:  Obstet Gynecol       Date:  1988-06       Impact factor: 7.661

7.  Adenocarcinoma in situ of the cervix: significance of cone biopsy margins.

Authors:  J K Wolf; C Levenback; A Malpica; M Morris; T Burke; M F Mitchell
Journal:  Obstet Gynecol       Date:  1996-07       Impact factor: 7.661

Review 8.  2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ.

Authors:  Thomas C Wright; L Stewart Massad; Charles J Dunton; Mark Spitzer; Edward J Wilkinson; Diane Solomon
Journal:  Am J Obstet Gynecol       Date:  2007-10       Impact factor: 8.661

9.  Adenocarcinoma in situ of the uterine cervix: a metaanalysis of 1278 patients evaluating the predictive value of conization margin status.

Authors:  Ritu Salani; Isha Puri; Robert E Bristow
Journal:  Am J Obstet Gynecol       Date:  2008-11-18       Impact factor: 8.661

10.  Fertility-sparing surgery in 101 women with adenocarcinoma in situ of the cervix.

Authors:  Shawna L Bull-Phelps; Elizabeth I O Garner; Christine S Walsh; Paola A Gehrig; David S Miller; John O Schorge
Journal:  Gynecol Oncol       Date:  2007-08-08       Impact factor: 5.482
View more
  1 in total

1.  Risk of residual disease and invasive carcinoma in women treated for adenocarcinoma in situ of the cervix.

Authors:  Anthony B Costales; Andrea M Milbourne; Helen E Rhodes; Mark F Munsell; John J Wallbillich; Jubilee Brown; Michael Frumovitz; Lois M Ramondetta; Kathleen M Schmeler
Journal:  Gynecol Oncol       Date:  2013-03-28       Impact factor: 5.482
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.